Selecta picks up grant for HPV research; Primate deaths spur Ag investigation; Lilly partners on diabetes research;

> Watertown, MA-based Selecta Biosciences has been awarded a $3.2 million grant from the Skolkovo Foundation in support of Selecta's program to develop an SVP immunotherapy to treat cancers caused by infections with Human Papilloma Virus. Release

> The U.S. Department of Agriculture is considering penalizing Covance ($CVD) after the failure of a thermostat override switch on two occasions, killing 13 primates at a South Texas facility. "Covance takes very seriously our ethical and regulatory responsibilities to treat research animals with the utmost care and respect," the company said in a statement to the AP. Report

> Eli Lilly ($LLY) announced a 5-year research partnership with the University of Surrey to study health outcomes, focusing on the effects of treatment in people with Type 2 diabetes. Release

Suggested Articles

German scientists are targeting a protein-cutting enzyme that many viruses, including the coronavirus COVID-19, need to replicate.

UPenn scientists found blocking the Wnt/beta-catenin pathway in endothelial cells made chemotherapy more effective in mouse models of glioblastoma.

Astellas’ Xospata and Novartis’ Rydapt may help treat lung cancer that has grown resistant to EGFR inhibitors, researchers discovered.